Literature DB >> 25287669

Gastroprotective effects of L-lysine salification of ketoprofen in ethanol-injured gastric mucosa.

Annamaria Cimini1, Laura Brandolini, Roberta Gentile, Loredana Cristiano, Paola Menghini, Alessia Fidoamore, Andrea Antonosante, Elisabetta Benedetti, Antonio Giordano, Marcello Allegretti.   

Abstract

Ketoprofen L-lysine salt (KLS), a NSAID, is widely used for its analgesic efficacy and tolerability. L-lysine salification was reported to increase the solubility and the gastric absorption and tolerance of ketoprofen. Since the management of NSAIDs gastrotoxicity still represents a major limitation in prolonged therapies, mainly when gastric lesions are present, this study investigated the gastro-protective activity of L-lysine by using a well-established model of gastric mucosa injury, the ethanol-gastric injury model. Several evidences show that the damaging action of ethanol could be attributed to the increase of ROS, which plays a key role in the increase of lipid peroxidation products, including malonyldialdehyde and 4-hydroxy-2-nonenal. With the aim to unravel the mechanism of L-lysine gastroprotection, cellular MDA levels and 4-HNE protein adducts as markers of lipid peroxidation and a panel of key endogenous gastro-protective proteins were assayed. The data obtained indicate a gastroprotective effect of L-lysine on gastric mucosa integrity.
© 2014 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25287669     DOI: 10.1002/jcp.24809

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  2 in total

1.  Towards an Effective and Safe Treatment of Inflammatory Pain: A Delphi-Guided Expert Consensus.

Authors:  Giustino Varrassi; Eli Alon; Michela Bagnasco; Luigi Lanata; Victor Mayoral-Rojals; Antonella Paladini; Joseph V Pergolizzi; Serge Perrot; Carmelo Scarpignato; Thomas Tölle
Journal:  Adv Ther       Date:  2019-08-16       Impact factor: 3.845

2.  Tumor suppressor miR-449a inhibits the development of gastric cancer via down-regulation of SGPL1.

Authors:  Qian Chen; Zhen Yang; Gaofeng Pan; Hongjian Ding; Daowen Jiang; Jianfang Huang; Weiyan Liu
Journal:  RSC Adv       Date:  2018-07-19       Impact factor: 4.036

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.